By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ionis Pharmaceuticals 

2855 Gazelle Court

Carlsbad  California  92010  U.S.A.
Phone: 760-931-9200 Fax: n/a


Ionis Pharmaceuticals, Inc., located in the North San Diego County city of Carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. We are the pioneer in the discovery and development of antisense drugs with more than 1300 patents.

Ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. Our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. We are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. Join us and experience our unique culture while you develop and expand your career.

See Collaborations

Key Statistics

Ownership: Public

Web Site: Ionis Pharma
Employees: 400+
Symbol: IONS


Company News
Ionis Pharma (IONS) And Akcea Therapeutics Close On Strategic Collaboration With Global Pharmaceutical Company To Develop And Commercialize AKCEA-APO(A)-Lrx And AKCEA-APOCIII-Lrx 2/16/2017 8:09:10 AM
Ionis Pharma (IONS) To Hold 2016 Financial Results Conference Call 2/15/2017 9:00:33 AM
Ionis Pharma (IONS) Earns $75 Million From Bayer (BAY) For Advancing IONIS-FXI Rx And IONIS-FXI-L Rx 2/14/2017 6:51:03 AM
Ionis Pharma (IONS) Significantly Improves Upon 2016 Financial Guidance 1/9/2017 10:23:01 AM
SoCal's Ionis Pharma (IONS) Stock Jolted by $1.6 Billion Cardio Drug Deal With This Big Pharma 1/6/2017 5:40:28 AM
Ionis Pharma (IONS) Reports Positive Data From Phase 2 Study Of IONIS-GCGR Rx In Patients With Type 2 Diabetes 1/4/2017 6:18:02 AM
FDA Approves First-Ever Treatment for Spinal Muscular Atrophy; Ionis Pharma (IONS), Biogen (BIIB) Seal Victory 12/27/2016 8:23:05 AM
Ionis Pharma (IONS) Earns Milestone Payment From Janssen For Advancing A New Program Under GI Collaboration 12/22/2016 7:56:35 AM
Ionis Pharma (IONS) And AstraZeneca PLC (AZN) Advance First Generation 2.5 LICA Drug Into Preclinical Development To Treat Cardiovascular Disease 12/20/2016 9:11:41 AM
Akcea Therapeutics, Ionis Pharma (IONS) Phase 3 COMPASS Met Primary Endpoint 12/19/2016 8:13:35 AM